APA (7th ed.) Citation

Krämer, I., Stilgenbauer, S., Dietrich, S., Böttcher, S., Hegenbart, U., Ho, A. D., & Dreger, P. (2017). Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood, 130(12), . https://doi.org/10.1182/blood-2017-04-775841

Chicago Style (17th ed.) Citation

Krämer, Isabelle, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Ute Hegenbart, Anthony Dick Ho, and Peter Dreger. "Allogeneic Hematopoietic Cell Transplantation for High-risk CLL: 10-year Follow-up of the GCLLSG CLL3X Trial." Blood 130, no. 12 (2017). https://doi.org/10.1182/blood-2017-04-775841.

MLA (9th ed.) Citation

Krämer, Isabelle, et al. "Allogeneic Hematopoietic Cell Transplantation for High-risk CLL: 10-year Follow-up of the GCLLSG CLL3X Trial." Blood, vol. 130, no. 12, 2017, https://doi.org/10.1182/blood-2017-04-775841.